UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000037492
Receipt No. R000042719
Scientific Title Effect of prophylaxis using 1% chlorhexidine gluconate and chlorhexidine-gel-impregnated dressings on central venous catheter-related thrombosis and infections in critically ill patients: a retrospective observational study.
Date of disclosure of the study information 2019/07/25
Last modified on 2019/07/25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Study using chlorhexidine on catheter related thrombosis and infections.
Acronym Study using chlorhexidine on catheter related thrombosis and infections.
Scientific Title Effect of prophylaxis using 1% chlorhexidine gluconate and chlorhexidine-gel-impregnated dressings on central venous catheter-related thrombosis and infections in critically ill patients: a retrospective observational study.
Scientific Title:Acronym Study using chlorhexidine on catheter related thrombosis and infections.
Region
Japan

Condition
Condition Patients who required central venous catheter for more than 48 hours in intensive care unit
Classification by specialty
Intensive care medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 This study aimed to determine the prophylactic effect of a 1% alcoholic chlorhexidine gluconate and chlorhexidine-gel-impregnated dressing combination on catheter-related thrombosis, which is a known risk factor for catheter-related bloodstream infections, in critically ill patients.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Catheter-related thrombosis within 14 days of catheter insertion
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria We included patients who required central venous catheter (CVC) for more than 48 hours in the intensive care unit(ICU). Patients whose CVCs were inserted in the ICU or operating room were included. Catheters inserted via the internal jugular vein were included. 12-gauge triple lumina CVCs were used.
Key exclusion criteria We excluded patients who were inserted in places outside the intensive care unit (ICU) or operating room, or whose catheters inserted via the subclavian or femoral veins, or who were less than 48 hours in ICU, or who had a history of hypersensitivity for chlorhexidine.
Target sample size 150

Research contact person
Name of lead principal investigator
1st name Tomoko
Middle name
Last name Yamashita
Organization Saga University Hospital
Division name Intensive Care Unit
Zip code 849-8501
Address 5-1-1, Nabeshima, Saga City, Saga, Japan.
TEL 0952-34-2324
Email yamadato@cc.saga-u.ac.jp

Public contact
Name of contact person
1st name Tomoko
Middle name
Last name Yamashita
Organization Saga University Hospital
Division name Intensive Care Unit
Zip code 849-8501
Address 5-1-1, Nabeshima, Saga City, Saga, Japan.
TEL 0952-34-2324
Homepage URL
Email yamadato@cc.saga-u.ac.jp

Sponsor
Institute Intensive Care Unit, Saga University Hospital
Institute
Department

Funding Source
Organization Department of Anesthesiology and Critical Care Medicine, Faculty of Medicine, Saga University
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Clinical Research Center, Saga University Hospital
Address 5-1-1, Nabeshima, Saga City, Saga, Japan.
Tel 0952-34-3400
Email kenkyu-shinsei@ml.cc.saga-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2019 Year 07 Month 25 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled 134
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 06 Month 08 Day
Date of IRB
2014 Year 07 Month 07 Day
Anticipated trial start date
2014 Year 07 Month 17 Day
Last follow-up date
2019 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information We included all patients who matched the inclusion criteria, who managed in the intensive care unit between November 2009-December 2010 and September 2012-December 2014, in this study.

Management information
Registered date
2019 Year 07 Month 25 Day
Last modified on
2019 Year 07 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042719

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.